The trial has enrolled 201 patients with localized prostate cancer to date.
Preston C. Sprenkle, MD
Advertisement
Articles by Preston C. Sprenkle, MD
Advertisement
Latest Updated Articles
Advertisement
Advertisement
Trending on Urology Times
1
CORE-008: Cretostimogene achieves high CR rate in high-risk NMIBC
2
Gemcitabine intravesical system delivers high 12-month DFS in papillary-only NMIBC
3
Choosing salvage therapy after prostate cancer focal ablation
4
SYNC-T demonstrates high bone metastasis resolution in phase 1 cohort
5
